J&J Unit's Topamax Warnings Were Inadequate, Jury Told

Law360, Philadelphia (March 4, 2014, 5:38 PM EST) -- A Johnson & Johnson unit's failure to warn doctors about the risks associated with the epilepsy medication Topamax resulted in a Wisconsin couple's child being born with birth defects, an attorney for the family told a jury during closing arguments in a Pennsylvania court trial on Tuesday.

David Matthews, an attorney with Matthews & Associates representing the family of 5-year-old Payton Anderson, told a jury in the Philadelphia County Court of Common Pleas that Janssen Pharmaceuticals Inc. had failed to update Topamax's label to reflect data...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.